U.S. Venture Partners XI L.P. 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-01 1:38 pm Sale | 2022-02-25 | 13D | Edgewise Therapeutics, Inc. EWTX | U.S. Venture Partners XI L.P. | 15,625 0.000% | -3,473,543 (-99.55%) | Filing |
| 2021-04-30 6:44 pm Purchase | 2021-03-30 | 13D | Edgewise Therapeutics, Inc. EWTX | U.S. Venture Partners XI L.P. | 3,489,168 7.100% | 3,489,168 (New Position) | Filing |